Price
Target price
?
?
13.020%
0.022
13.020%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Relief Therapeutics Holding
sharewise wants to provide you with the best news and tools for Relief Therapeutics Holding, so we directly link to the best financial data sources.
Financials
News
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe
MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe
MindMaze Therapeutics Announces Results of Annual General Meeting
MindMaze Therapeutics Announces Results of Annual General Meeting
MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting
MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting
MindMaze Therapeutics Announces Non-Core Asset Sale and Organizational Simplification
MindMaze Therapeutics Announces Non-Core Asset Sale and Organizational Simplification
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
MindMaze Therapeutics and Vibra Healthcare Announce Go-to-Market Partnership to Expand Commercial Footprint of Precision Neurotherapeutics in the U.S.
MindMaze Therapeutics and Vibra Healthcare Announce Go-to-Market Partnership to Expand Commercial Footprint of Precision Neurotherapeutics in the U.S.
MindMaze Therapeutics Publishes 2025 Annual Report and Corporate Update
MindMaze Therapeutics Publishes 2025 Annual Report and Corporate Update
MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough RWE Results in High-Dose, High-Intensity Neurorehabilitation
MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough RWE Results in High-Dose, High-Intensity Neurorehabilitation
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation